Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Acta Anaesthesiol Scand
1 Actas Urol Esp
1 Bioconjug Chem
10 Bladder Cancer
1 Br J Cancer
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
3 Cell Death Dis
1 Clin Epigenetics
1 Clin Lung Cancer
4 Eur Urol
1 Eur Urol Focus
1 Expert Rev Anticancer Ther
1 Fam Cancer
1 Future Cardiol
1 In Vivo
1 Int J Clin Oncol
1 J Endourol
1 J Radiat Res
2 Medicine (Baltimore)
1 Nat Rev Urol
5 Oncol Lett
1 Oncol Res
1 Oncotarget
1 Pan Afr Med J
1 Pharmazie
1 PLoS One
2 Urol Oncol
1 World J Urol
1 Zhonghua Yi Xue Za Zhi

    Acta Anaesthesiol Scand

  1. KIM HC, Park HP, Lee J, Jeong MH, et al
    Sevoflurane vs. propofol in post-operative catheter-related bladder discomfort: a prospective randomized study.
    Acta Anaesthesiol Scand. 2017;61:773-780.
    >> Share

    Actas Urol Esp

  2. RIVERO GUERRA A, Fernandez Aparicio T, Barcelo Bayonas I, Pardo Martinez A, et al
    Outpatient Holmium laser fulguration: A safe procedure for treatment of recurrence of nonmuscle invasive bladder cancer.
    Actas Urol Esp. 2018 Feb 5. pii: S0210-4806(18)30003.
    >> Share

    Bioconjug Chem

  3. PAQUETTE M, Beaudoin S, Tremblay MA, Jean S, et al
    NLS-cholic acid conjugation to IL-5Ralpha-specific antibody improves cellular accumulation and in vivo tumor-targeting properties in a bladder cancer model.
    Bioconjug Chem. 2018 Feb 13. doi: 10.1021/acs.bioconjchem.8b00077.
    >> Share

    Bladder Cancer

    Molecular Landscape of Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:131-132.
    >> Share

  5. GARG T, Connors JN, Ladd IG, Bogaczyk TL, et al
    Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:121-128.
    >> Share

  6. FARBER NJ, Faiena I, Dombrovskiy V, Tabakin AL, et al
    Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.
    Bladder Cancer. 2018;4:113-120.
    >> Share

  7. WESTHOFF E, Witjes JA, Fleshner NE, Lerner SP, et al
    Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis.
    Bladder Cancer. 2018;4:91-112.
    >> Share

  8. TAMURA S, Wang Y, Veeneman B, Hovelson D, et al
    Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
    Bladder Cancer. 2018;4:77-90.
    >> Share

  9. WALKER M, Doiron RC, French SD, Brennan K, et al
    Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.
    Bladder Cancer. 2018;4:49-65.
    >> Share

  10. LI R, Metcalfe M, Kukreja J, Navai N, et al
    Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review.
    Bladder Cancer. 2018;4:31-40.
    >> Share

  11. ABBOSH PH, Plimack ER
    Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer.
    Bladder Cancer. 2018;4:9-18.
    >> Share

  12. TODENHOFER T, Struss WJ, Seiler R, Wyatt AW, et al
    Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.
    Bladder Cancer. 2018;4:19-29.
    >> Share

  13. SHERIF A, Winerdal M, Winqvist O
    Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:1-7.
    >> Share

    Br J Cancer

  14. SAKAGUCHI T, Yoshino H, Yonemori M, Miyamoto K, et al
    Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Br J Cancer. 2018 Feb 13. pii: bjc2017439. doi: 10.1038/bjc.2017.
    >> Share

    Cancer Epidemiol Biomarkers Prev

  15. KOESTLER DC, Usset J, Christensen BC, Marsit CJ, et al
    DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2017;26:328-338.
    >> Share

    Cancer Res

  16. DAIZUMOTO K, Yoshimaru T, Matsushita Y, Fukawa T, et al
    A DDX31/mutant-p53/EGFR axis promotes multistep progression of muscle invasive bladder cancer.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2528.
    >> Share

    Cell Death Dis

  17. SU F, He W, Chen C, Liu M, et al
    The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Cell Death Dis. 2018;9:233.
    >> Share

  18. WANG M, Guo C, Wang L, Luo G, et al
    Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription.
    Cell Death Dis. 2018;9:238.
    >> Share

  19. XU M, Li J, Wang X, Meng S, et al
    MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
    Cell Death Dis. 2018;9:209.
    >> Share

    Clin Epigenetics

  20. MIJNES J, Veeck J, Gaisa NT, Burghardt E, et al
    Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer.
    Clin Epigenetics. 2018;10:15.
    >> Share

    Clin Lung Cancer

  21. WU GX, Nelson RA, Kim JY, Raz DJ, et al
    Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Clin Lung Cancer. 2017 Mar 2. pii: S1525-7304(17)30050.
    >> Share

    Eur Urol

  22. BABJUK M, Bohle A, Burger M, Capoun O, et al
    EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Eur Urol. 2017;71:447-461.
    >> Share

  23. GAKIS G, Black PC, Bochner BH, Boorjian SA, et al
    Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Eur Urol. 2017;71:545-557.
    >> Share

  24. COLLINS JW, Hosseini A, Adding C, Nyberg T, et al
    Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group.
    Eur Urol. 2017;71:723-726.
    >> Share

  25. DY GW, Gore JL, Forouzanfar MH, Naghavi M, et al
    Global Burden of Urologic Cancers, 1990-2013.
    Eur Urol. 2017;71:437-446.
    >> Share

    Eur Urol Focus

  26. ZHANG S, Wang Y, Bondaruk J, Majewski T, et al
    Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
    Eur Urol Focus. 2018 Feb 7. pii: S2405-4569(18)30018.
    >> Share

    Expert Rev Anticancer Ther

  27. MARCHIONI M, Nazzani S, Preisser F, Bandini M, et al
    Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy.
    Expert Rev Anticancer Ther. 2018 Feb 15:1-11. doi: 10.1080/14737140.2018.1439744
    >> Share

    Fam Cancer

  28. FREMEREY J, Balzer S, Brozou T, Schaper J, et al
    Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome.
    Fam Cancer. 2017;16:401-405.
    >> Share

    Future Cardiol

  29. MOHANTY BD, Mohanty S, Hussain Y, Padmaraju C, et al
    Management of ischemic coronary disease in patients receiving chemotherapy: an uncharted clinical challenge.
    Future Cardiol. 2017;13:247-257.
    >> Share

    In Vivo

  30. MANIG L, Janssen S, Schild SE, Rades D, et al
    A New Prognostic Instrument Specifically Designed for Patients Irradiated for Recurrent Carcinoma of the Bladder.
    In Vivo. 2017;31:435-438.
    >> Share

    Int J Clin Oncol

  31. HIROBE M, Tanaka T, Shindo T, Ichihara K, et al
    Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.
    Int J Clin Oncol. 2018 Feb 13. pii: 10.1007/s10147-018-1245.
    >> Share

    J Endourol

  32. DUTTA R, Yoon R, Patel RM, Spradling K, et al
    Clinical Comparison of Conventional and Mobile Endockscope Videocystoscopy Using an Air or Fluid Medium.
    J Endourol. 2017;31:593-597.
    >> Share

    J Radiat Res

  33. SHIBA S, Wakatsuki M, Kato S, Ohno T, et al
    Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion.
    J Radiat Res. 2016.
    >> Share

    Medicine (Baltimore)

  34. CORMIO L, Mancini V, Calo B, Selvaggio O, et al
    Asymptomatic solitary bladder plasmocytoma: A case report and literature review.
    Medicine (Baltimore). 2017;96:e9347.
    >> Share

  35. FEDUS T, Ras R, Ksiazek M, Filipowska J, et al
    Primary vaginal squamous cell carcinoma with bladder involvement in uterine prolapsed patient: Case report.
    Medicine (Baltimore). 2017;96:e8993.
    >> Share

    Nat Rev Urol

  36. KELSEY R
    Bladder cancer: BBN mouse model mimics human MIBC.
    Nat Rev Urol. 2018 Feb 13. pii: nrurol.2018.17. doi: 10.1038/nrurol.2018.
    >> Share

    Oncol Lett

  37. ZHOU YM, Feng X, Zhou BC, Fan YF, et al
    Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer.
    Oncol Lett. 2018;15:3453-3457.
    >> Share

  38. XIANG X, Huang J, Mo W, Jiang L, et al
    Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer.
    Oncol Lett. 2018;15:3049-3055.
    >> Share

  39. LI Z, Zhang TB, Jia DH, Sun WQ, et al
    Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3K/Akt signaling.
    Oncol Lett. 2018;15:2619-2624.
    >> Share

  40. MEMON AA, Gilliver SC, Borre M, Sundquist J, et al
    Soluble HER3 predicts survival in bladder cancer patients.
    Oncol Lett. 2018;15:1783-1788.
    >> Share

  41. MA Z, Xue S, Zeng B, Qiu D, et al
    lncRNA SNHG5 is associated with poor prognosis of bladder cancer and promotes bladder cancer cell proliferation through targeting p27.
    Oncol Lett. 2018;15:1924-1930.
    >> Share

    Oncol Res

  42. LIU X, Li S, Li Y, Cheng B, et al
    Puerarin inhibits proliferation and induces apoptosis by up-regulation of miR-16 in bladder cancer cell line T24.
    Oncol Res. 2018 Feb 8. doi: 10.3727/096504018X15178736525106.
    >> Share


  43. CHEN QN, Wei CC, Wang ZX, Sun M, et al
    Long non-coding RNAs in anti-cancer drug resistance.
    Oncotarget. 2017;8:1925-1936.
    >> Share

    Pan Afr Med J

  44. EL BOTE H, Atik S, Fares R, Hage E, et al
    [Inverted papilloma of the bladder: a rare benign tumor: a case report].
    Pan Afr Med J. 2017;26:204.
    >> Share


  45. HUANG XX, Wang RX, Lin Q, Chen W, et al
    Inhibitory effects of 2-methoxyestradiol on cell growth and invasion in human bladder cancer T-24 cells.
    Pharmazie. 2017;72:87-90.
    >> Share

    PLoS One

  46. KIM M, Oh SJ, Kwak C, Kim HH, et al
    Psychometric validation study of the Korean version of the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index.
    PLoS One. 2018;13:e0190570.
    >> Share

    Urol Oncol

  47. ALLIONE A, Pardini B, Viberti C, Oderda M, et al
    The prognostic value of basal DNA damage level in peripheral blood lymphocytes of patients affected by bladder cancer.
    Urol Oncol. 2018 Feb 6. pii: S1078-1439(18)30006.
    >> Share

  48. MUKHERJEE N, Svatek RS, Mansour AM
    Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer.
    Urol Oncol. 2018 Feb 8. pii: S1078-1439(17)30649.
    >> Share

    World J Urol

  49. FANG CW, Liao CH, Wu SC, Muo CH, et al
    Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.
    World J Urol. 2018 Feb 9. pii: 10.1007/s00345-018-2216.
    >> Share

    Zhonghua Yi Xue Za Zhi

  50. LI WL, Ji GH, Zhang XZ, Yu HY, et al
    [The influence and mechanisms of purple sweet potato anthocyanins on the growth of bladder cancer BIU87 cell].
    Zhonghua Yi Xue Za Zhi. 2018;98:457-459.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016